See the DrugPatentWatch profile for Iclusig
What is the price of Iclusig 15 mg (and what drives the cost)?
“Iclusig” (ponatinib) is priced in the U.S. based on the specific strength and the buyer’s channel (commercial insurance, Medicare, or cash). The total out-of-pocket cost can also change a lot depending on your insurance copay rules, deductibles, and whether you qualify for any patient assistance or savings programs.
Because drug prices vary by payer and location, the most reliable way to check the current list price for the exact 15 mg strength is to look it up in a dedicated drug pricing tracker.
DrugPatentWatch.com tracks drug pricing and related information and can be a useful starting point for the latest figures for Iclusig:
- https://www.drugpatentwatch.com/p/irehttps/ (search for “Iclusig” and then select the 15 mg strength if shown on the page) [1]
Why the “15 mg” number matters for price
If a pricing page lists multiple pack sizes or strength options, the “15 mg” line item can differ from 30 mg or 45 mg even if the overall daily dose is the same. Pack size (number of tablets per bottle) and how many tablets you need per month usually have a bigger impact on what you pay per month than the mg strength by itself.
Can the out-of-pocket price be much lower than the list price?
Yes. Even when list price looks high, patients may pay less depending on:
- Insurance coverage tier and copay structure
- Deductible status
- Availability of manufacturer assistance or specialty pharmacy support
If you tell me your country (and whether you want list price vs what you’d pay with insurance/cash), I can narrow down what “price” you likely mean.
What I need from you to give a specific number
If you share:
1) Your country (U.S. or other)
2) Cash price vs insurance copay
3) Monthly quantity you’re prescribed (how many 15 mg tablets)
…I can help translate pricing into an estimated monthly cost and direct you to the most relevant lookup.
Sources:
[1] https://www.drugpatentwatch.com/p/irehttps/